Optigrid® 45 is comprised of the active ingredient ractopamine hydrochloride. It can be fed as a complete feed or top dress feed to cattle fed in confinement for slaughter during the last 28 to 42 days on feed prior to harvest.
• Complete Feed: For increased rate of weight gain, improved feed efficiency and increased carcass leanness in cattle fed in confinement for slaughter during the last 28 to 42 days on feed.
• Top Dress Feed: For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed.
Note: Carcass leanness effects are not an approved indication for use when feeding ractopamine by Top Dress Feeding methods.
Store at less than or equal to 25°C (77°F).
For use in feeds for cattle fed in confinement for slaughter only
Do not feed undiluted
Optigrid® 45 (ractopamine hydrochloride Type A medicated article): Not for human use. For use in feeds for cattle fed in confinement for slaughter. Not for animals intended for breeding. No withdrawal is necessary if directions are followed. The active ingredient in Optigrid 45, ractopamine hydrochloride, is a Beta-adrenergic agonist. Individuals with cardiovascular disease should exercise special caution to avoid exposure. Not for use in humans. Keep out of the reach of children. The Optigrid 45 formulation (Type A Medicated Article) poses a low dust potential under usual conditions of handling and mixing. When mixing and handling Optigrid 45 use protective clothing, impervious gloves, protective eye wear, and a NIOSH-approved dust mask. Operators should wash thoroughly with soap and water after handling. If accidental eye contact occurs, immediately rinse eyes thoroughly with water. If irritation persists, seek medical attention. The Safety Data Sheet (SDS) contains more detailed occupational safety information. To report suspected adverse drug events, for technical assistance or to obtain a copy of the SDS, contact Huvepharma, Inc. at 1-877-994-4883 or www.huvepharma.us. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or http://www.fda.gov/reportanimalae.
